Copyright Reports & Markets. All rights reserved.

Global In Vitro Diagnostic/IVD Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global In Vitro Diagnostic/IVD Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Instruments
      • 1.4.3 Reagents
    • 1.5 Market by Application
      • 1.5.1 Global In Vitro Diagnostic/IVD Market Share by Application (2014-2025)
      • 1.5.2 Diabetes
      • 1.5.3 Oncology
      • 1.5.4 Cardiology
      • 1.5.5 Nephrology
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 In Vitro Diagnostic/IVD Market Size
    • 2.2 In Vitro Diagnostic/IVD Growth Trends by Regions
      • 2.2.1 In Vitro Diagnostic/IVD Market Size by Regions (2014-2025)
      • 2.2.2 In Vitro Diagnostic/IVD Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 In Vitro Diagnostic/IVD Market Size by Manufacturers
      • 3.1.1 Global In Vitro Diagnostic/IVD Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global In Vitro Diagnostic/IVD Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global In Vitro Diagnostic/IVD Market Concentration Ratio (CR5 and HHI)
    • 3.2 In Vitro Diagnostic/IVD Key Players Head office and Area Served
    • 3.3 Key Players In Vitro Diagnostic/IVD Product/Solution/Service
    • 3.4 Date of Enter into In Vitro Diagnostic/IVD Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global In Vitro Diagnostic/IVD Market Size by Type (2014-2019)
    • 4.2 Global In Vitro Diagnostic/IVD Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States In Vitro Diagnostic/IVD Market Size (2014-2019)
    • 5.2 In Vitro Diagnostic/IVD Key Players in United States
    • 5.3 United States In Vitro Diagnostic/IVD Market Size by Type
    • 5.4 United States In Vitro Diagnostic/IVD Market Size by Application

    6 Europe

    • 6.1 Europe In Vitro Diagnostic/IVD Market Size (2014-2019)
    • 6.2 In Vitro Diagnostic/IVD Key Players in Europe
    • 6.3 Europe In Vitro Diagnostic/IVD Market Size by Type
    • 6.4 Europe In Vitro Diagnostic/IVD Market Size by Application

    7 China

    • 7.1 China In Vitro Diagnostic/IVD Market Size (2014-2019)
    • 7.2 In Vitro Diagnostic/IVD Key Players in China
    • 7.3 China In Vitro Diagnostic/IVD Market Size by Type
    • 7.4 China In Vitro Diagnostic/IVD Market Size by Application

    8 Japan

    • 8.1 Japan In Vitro Diagnostic/IVD Market Size (2014-2019)
    • 8.2 In Vitro Diagnostic/IVD Key Players in Japan
    • 8.3 Japan In Vitro Diagnostic/IVD Market Size by Type
    • 8.4 Japan In Vitro Diagnostic/IVD Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia In Vitro Diagnostic/IVD Market Size (2014-2019)
    • 9.2 In Vitro Diagnostic/IVD Key Players in Southeast Asia
    • 9.3 Southeast Asia In Vitro Diagnostic/IVD Market Size by Type
    • 9.4 Southeast Asia In Vitro Diagnostic/IVD Market Size by Application

    10 India

    • 10.1 India In Vitro Diagnostic/IVD Market Size (2014-2019)
    • 10.2 In Vitro Diagnostic/IVD Key Players in India
    • 10.3 India In Vitro Diagnostic/IVD Market Size by Type
    • 10.4 India In Vitro Diagnostic/IVD Market Size by Application

    11 Central & South America

    • 11.1 Central & South America In Vitro Diagnostic/IVD Market Size (2014-2019)
    • 11.2 In Vitro Diagnostic/IVD Key Players in Central & South America
    • 11.3 Central & South America In Vitro Diagnostic/IVD Market Size by Type
    • 11.4 Central & South America In Vitro Diagnostic/IVD Market Size by Application

    12 International Players Profiles

    • 12.1 Roche Diagnostics (Switzerland)
      • 12.1.1 Roche Diagnostics (Switzerland) Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 In Vitro Diagnostic/IVD Introduction
      • 12.1.4 Roche Diagnostics (Switzerland) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
      • 12.1.5 Roche Diagnostics (Switzerland) Recent Development
    • 12.2 Siemens Healthineers (Germany)
      • 12.2.1 Siemens Healthineers (Germany) Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 In Vitro Diagnostic/IVD Introduction
      • 12.2.4 Siemens Healthineers (Germany) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
      • 12.2.5 Siemens Healthineers (Germany) Recent Development
    • 12.3 Danaher Corporation (US)
      • 12.3.1 Danaher Corporation (US) Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 In Vitro Diagnostic/IVD Introduction
      • 12.3.4 Danaher Corporation (US) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
      • 12.3.5 Danaher Corporation (US) Recent Development
    • 12.4 Abbott Laboratories (US)
      • 12.4.1 Abbott Laboratories (US) Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 In Vitro Diagnostic/IVD Introduction
      • 12.4.4 Abbott Laboratories (US) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
      • 12.4.5 Abbott Laboratories (US) Recent Development
    • 12.5 Thermo Fisher Scientific (US)
      • 12.5.1 Thermo Fisher Scientific (US) Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 In Vitro Diagnostic/IVD Introduction
      • 12.5.4 Thermo Fisher Scientific (US) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
      • 12.5.5 Thermo Fisher Scientific (US) Recent Development
    • 12.6 Johnson & Johnson (US)
      • 12.6.1 Johnson & Johnson (US) Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 In Vitro Diagnostic/IVD Introduction
      • 12.6.4 Johnson & Johnson (US) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
      • 12.6.5 Johnson & Johnson (US) Recent Development
    • 12.7 Bio-Rad Laboratories (US)
      • 12.7.1 Bio-Rad Laboratories (US) Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 In Vitro Diagnostic/IVD Introduction
      • 12.7.4 Bio-Rad Laboratories (US) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
      • 12.7.5 Bio-Rad Laboratories (US) Recent Development
    • 12.8 Sysmex Corporation (Japan)
      • 12.8.1 Sysmex Corporation (Japan) Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 In Vitro Diagnostic/IVD Introduction
      • 12.8.4 Sysmex Corporation (Japan) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
      • 12.8.5 Sysmex Corporation (Japan) Recent Development
    • 12.9 bioMérieux (France)
      • 12.9.1 bioMérieux (France) Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 In Vitro Diagnostic/IVD Introduction
      • 12.9.4 bioMérieux (France) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
      • 12.9.5 bioMérieux (France) Recent Development
    • 12.10 DiaSorin (Italy)
      • 12.10.1 DiaSorin (Italy) Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 In Vitro Diagnostic/IVD Introduction
      • 12.10.4 DiaSorin (Italy) Revenue in In Vitro Diagnostic/IVD Business (2014-2019)
      • 12.10.5 DiaSorin (Italy) Recent Development
    • 12.11 Ortho Clinical Diagnostics (US)
    • 12.12 Agilent Technologies (US)
    • 12.13 QIAGEN (Germany)

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
      Increasing incidence of sexually transmitted and gastrointestinal diseases coupled with surging demand for large-scale screening, particularly for cancer, is stimulating the growth of the market. IVD helps in detecting whether a particular medicine or treatment would work on a patient.
      In 2018, the global In Vitro Diagnostic/IVD market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global In Vitro Diagnostic/IVD status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In Vitro Diagnostic/IVD development in United States, Europe and China.

      The key players covered in this study
      Roche Diagnostics (Switzerland)
      Siemens Healthineers (Germany)
      Danaher Corporation (US)
      Abbott Laboratories (US)
      Thermo Fisher Scientific (US)
      Johnson & Johnson (US)
      Bio-Rad Laboratories (US)
      Sysmex Corporation (Japan)
      bioMérieux (France)
      DiaSorin (Italy)
      Ortho Clinical Diagnostics (US)
      Agilent Technologies (US)
      QIAGEN (Germany)

      Market segment by Type, the product can be split into
      Instruments
      Reagents

      Market segment by Application, split into
      Diabetes
      Oncology
      Cardiology
      Nephrology

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global In Vitro Diagnostic/IVD status, future forecast, growth opportunity, key market and key players.
      To present the In Vitro Diagnostic/IVD development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of In Vitro Diagnostic/IVD are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now